Resolvin D1 attenuates inflammation in lipopolysaccharide-induced acute lung injury through a process involving the PPARγ/NF-κB pathway

Respiratory Research

Volumn 13, Issue , 2012, Pages

  Liao, Zenglin ^a   Dong, Jiajia ^a   Wu, Wei ^a   Yang, Ting ^a   Wang, Tao ^a   Guo, Lingli ^a   Chen, Lei ^a   Xu, Dan ^a   Wen, Fuqiang ^a  

^a SICHUAN UNIVERSITY   (China)

Author keywords

Acute lung injury; Docosahexaenoic acid; Lipid mediators; NF B; Peroxisome proliferator activated receptor gamma; Resolvin D1

Indexed keywords

2 CHLORO 5 NITROBENZANILIDE; CYTOKINE; DOCOSAHEXAENOIC ACID; ESCHERICHIA COLI LIPOPOLYSACCHARIDE; I KAPPA B ALPHA; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 6; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; RESOLVIN D1; SODIUM CHLORIDE; TRANSCRIPTION FACTOR RELA; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG; LIPOPOLYSACCHARIDE;

ACUTE LUNG INJURY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ANTIINFLAMMATORY ACTIVITY; ARTICLE; ATTENUATION; CELL COUNT; CONTROLLED STUDY; CYTOKINE PRODUCTION; DRUG EFFICACY; GEL MOBILITY SHIFT ASSAY; HISTOPATHOLOGY; IMMUNOHISTOCHEMISTRY; INFLAMMATION; LEUKOCYTE COUNT; LUNG LAVAGE; LUNG PARENCHYMA; MALE; MEDIATOR; MOUSE; NONHUMAN; PNEUMONIA; PROTEIN ANALYSIS; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN FUNCTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; ANIMAL; BAGG ALBINO MOUSE; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; METABOLISM; TREATMENT OUTCOME;

ACUTE LUNG INJURY; ANIMALS; DOCOSAHEXAENOIC ACIDS; LIPOPOLYSACCHARIDES; MALE; MICE; MICE, INBRED BALB C; NF-KAPPA B; PNEUMONIA; PPAR GAMMA; SIGNAL TRANSDUCTION; TREATMENT OUTCOME;

MLCS; MLOWN;

EID: 84870214188     PISSN: 14659921     EISSN: 1465993X     Source Type: Journal    
DOI: 10.1186/1465-9921-13-110     Document Type: Article

References (35)

1. Ferguson ND, Frutos-Vivar F, Esteban A, Fernández-Segoviano P, Aramburu JA, Nájera L, Stewart TE. Acute respiratory distress syndrome: underrecognition by clinicians and diagnostic accuracy of three clinical definitions. Crit Care Med 2005, 33(10):2228-2234. 10.1097/01.CCM.0000181529.08630.49, 16215375.
2. Levitt JE, Matthay MA. Treatment of acute lung injury: historical perspective and potential future therapies. Semin Respir Crit Care Med 2006, 27(4):426-437. 10.1055/s-2006-948296, 16909376.
3. Rubenfeld GD, Caldwell E, Peabody E, Weaver J, Martin DP, Neff M, Stern EJ, Hudson LD. Incidence and out-comes of acute lung injury. N Engl J Med 2005, 353(16):1685-1693. 10.1056/NEJMoa050333, 16236739.
4. Serhan CN, Krishnamoorthy S, Recchiuti A, Chiang N. Novel anti-inflammatory-pro-resolving mediators and their receptors. Curr Top Med Chem 2011, 11(6):629-647. 10.2174/1568026611109060629, 3094721, 21261595.
5. Bannenberg GL, Chiang N, Ariel A, Arita M, Tjonahen E, Gotlinger KH, Hong S, Serhan CN. Molecular circuits of resolution: formation and actions of resolvins and protectins. J Immunol 2005, 174(7):4345-4355.
6. Haworth O, Levy BD. Endogenous lipid mediators in the resolution of airway inflammation. Eur Respir J 2007, 30(5):980-992. 10.1183/09031936.00005807, 3005702, 17978156.
7. Draper E, Reynolds CM, Canavan M, Mills KH, Loscher CE, Roche HM. Omega-3 fatty acids attenuate dendritic cell function via NF-κB independent of PPARγ. J Nutr Biochem 2011, 22(8):784-790. 10.1016/j.jnutbio.2010.06.009, 21111596.
8. Chawla A, Repa JJ, Evans RM, Mangelsdorf DJ. Nuclear receptors and lipid physiology: opening the X-files. Science 2001, 294(5548):1866-1870. 10.1126/science.294.5548.1866, 11729302.
9. Wall R, Ross RP, Fitzgerald GF, Stanton C. Fatty acids from fish: the anti-inflammatory potential of long-chain omega-3 fatty acids. Nutr Rev 2010, 68(5):280-289. 10.1111/j.1753-4887.2010.00287.x, 20500789.
10. Jump DB, Clarke SD. Regulation of gene expression by dietary fat. Annu Rev Nutr 1999, 19:63-90. 10.1146/annurev.nutr.19.1.63, 10448517.
11. Poynter ME, Daynes RA. Peroxisome proliferator-activated receptor alpha activation mod ulates cellular redox status, represses nuclear factor-kappa B signaling, and reduces inflammatory cytokine production in aging. J Biol Chem 1998, 273(49):32833-32841. 10.1074/jbc.273.49.32833, 9830030.
12. Li H, Ruan XZ, Powis SH, Fernando R, Mon WY, Wheeler DC, Moorhead JF, Varghese Z. EPA and DHA reduce LPS-induced inflammation responses in HK-2 cells: evidence for a PPAR-gamma-dependent mechanism. Kidney Int 2005, 67(3):867-884. 10.1111/j.1523-1755.2005.00151.x, 15698426.
13. Rogerio AP, Haworth O, Croze R, Oh SF, Uddin M, Carlo T, Pfeffer MA, Priluck R, Serhan CN, Levy BD. Resolvin d1 and aspirin-triggered resolvin d1 promote resolution of allergic airways responses. J Immunol 2012, 189(4):1983-1991. 10.4049/jimmunol.1101665, 22802419.
14. Sun YP, Oh SF, Uddin J, Yang R, Gotlinger K, Campbell E, Colgan SP, Petasis NA, Serhan CN. Resolvin D1 and its aspirin-triggered 17R epimer stereochemical assignments, anti-inflammatory properties, and enzymatic inactivation. J Biol Chem 2007, 282(13):9323-9334. 10.1074/jbc.M609212200, 17244615.
15. Schwab JM, Chiang N, Arita M, Serhan CN. Resolvin E1 and protectin D1 activate inflammation-resolution programmes. Nature 2007, 447(7146):869-874. 10.1038/nature05877, 2757086, 17568749.
16. Collin M, Abdelrahman M, Thiemermann C. Endogenous ligands of PPAR-gamma reduce the liver injury in haemorrhagic shock. Eur J Pharmacol 2004, 486(2):233-235. 10.1016/j.ejphar.2003.12.032, 14975712.
17. Imanaka H, Shimaoka M, Matsuura N, Nishimura M, Ohta N, Kiyono H. Ventilator-induced lung injury is associated with neutrophil infiltration, macrophage activation, and TGF-beta 1 mRNA upregulation in rat lungs. Anesth Analg 2001, 92(2):428-436. 10.1213/00000539-200102000-00029, 11159246.
18. Jing X, Piao YF, Liu Y, Gao PJ. Beta2-GPI: a novel factor in the development of hepatocellular carcinoma. J Cancer Res Clin Oncol 2010, 136(11):1671-1680. 10.1007/s00432-010-0825-8, 20204408.
19. Minamino T, Komuro I. Regeneration of the endothelium as a novel therapeutic strategy for acute lung injury. J Clin Invest 2006, 116(9):2316-2319. 10.1172/JCI29637, 1555652, 16955131.
20. Calder PC. n-3 polyunsaturated fatty acids and cytokine production in health and disease. Ann Nutr Metab 1997, 41(4):203-234. 10.1159/000177997, 9363294.
21. Murakami T, Suzuki K, Tamura H, Nagaoka I. Suppressive action of resolvin D1 on the production and release of septic mediators in D-galactosamine-sensitized endotoxin shock mice. Experimental and Therapeutic Medicine 2011, 2(1):57-61. 3440633, 22977469.
22. Bento AF, Claudino RF, Dutra RC, Marcon R, Calixto JB. Omega-3 fatty acid-derived mediators 17(R)-hydroxy docosahexaenoic acid, aspirin-triggered resolvin D1 and resolvin D2 prevent experimental colitis in mice. J Immunol 2011, 187(4):1957-1969. 10.4049/jimmunol.1101305, 21724996.
23. Wang B, Gong X, Wan JY, Zhang L, Zhang Z, Li HZ, Min S. Resolvin D1 protects mice from LPS-induced acute lung injury. Pulm Pharmacol Ther 2011, 24(4):434-441. 10.1016/j.pupt.2011.04.001, 21501693.
24. Eickmeier O, Seki H, Haworth O, Hilberath JN, Gao F, Uddin M, Croze RH, Carlo T, Pfeffer MA, Levy BD. Aspirin-triggered resolvin D1 reduces mucosal inflammation and promotes resolution in a murine model of acute lung injury. Mucosal Immunol 2012, 11.
25. Serhan CN. Novel lipid mediators and resolution mechanisms in acute inflammation: to resolve or not?. Am J Patho 2010, 177(4):1576-1591.
26. Serhan CN, Chiang N, Van Dyke TE. Resolving inflammation: dual anti-inflammatory and pro-resolution lipid mediators. Nat Rev Immunol 2008, 8(5):349-361. 10.1038/nri2294, 2744593, 18437155.
27. Fialkow L, Fochesatto Filho L, Bozzetti MC, Milani AR, Rodrigues Filho EM, Ladniuk RM, Pierozan P, de Moura RM, Prolla JC, Vachon E, Downey GP. Neutrophil apoptosis: a marker of disease severity in sepsis and sepsis-induced acute respiratory distress syndrome. Crit Care 2006, 10(6):R155. 10.1186/cc5090, 1794458, 17092345.
28. Sookhai S, Wang JJ, McCourt M, Kirwan W, Bouchier-Hayes D, Redmond P. A novel therapeutic strategy for attenuating neutrophil-mediated lung injury in vivo. Ann Surg 2002, 235(2):285-291. 10.1097/00000658-200202000-00018, 1422426, 11807370.
29. Singer P, Shapiro H, Theilla M, Anbar R, Singer J, Cohen J. Anti-inflammatory properties of omega-3 fatty acids in critical illness: novel mechanisms and an integrative perspective. Intensive Care Med 2008, 34(9):1580-1592. 10.1007/s00134-008-1142-4, 18461305.
30. Bogazzi F, Russo D, Locci MT, Chifenti B, Ultimieri F, Raggi F, Viacava P, Cecchetti D, Cosci C, Sardella C, Acerbi G, Gasperi M, Martino E. Peroxisome proliferator-activated receptor (PPAR) gamma is highly expressed in normal human pituitary gland. J Endocrinol Invest 2005, 28(10):899-904.
31. Xu YW, Sun L, Liang H, Sun GM, Cheng Y. 12/15-Lipoxygenase inhibitor baicalein suppresses PPAR gamma expression and nuclear translocation induced by cerebral ischemia/reperfusion. Brain Res 2010, 1307:149-157.
32. Mishra A, Chaudhary A, Sethi S. Oxidized omega-3 fatty acids inhibit NF-kappa B activation via a PPAR alpha-dependent pathway. Arterioscler Thromb Vasc Biol 2004, 24(9):1621-1627. 10.1161/01.ATV.0000137191.02577.86, 15231516.
33. Fan J, Ye RD, Malik AB. Transcriptional mechanisms of acute lung injury. Am J Physiol Lung Cell Mol Physiol 2001, 281(5):L1037-L1050.
34. Krishnamoorthy S, Recchiuti A, Chiang N, Yacoubian S, Lee CH, Yang R, Petasis NA, Serhan CN. Resolvin D1 binds human phagocytes with evidence for proresolving receptors. Proc Natl Acad Sci USA 2010, 107(4):1660-1665. 10.1073/pnas.0907342107, 2824371, 20080636.
35. Oh DY, Talukdar S, Bae EJ, Imamura T, Morinaga H, Fan W, Li P, Lu WJ, Watkins SM, Olefsky JM. GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 2010, 142(5):687-698. 10.1016/j.cell.2010.07.041, 2956412, 20813258.